Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166969 | SCV000217790 | pathogenic | Hereditary cancer-predisposing syndrome | 2018-02-01 | criteria provided, single submitter | clinical testing | The c.394_409del16 pathogenic mutation, located in coding exon 4 of the TP53 gene, results from a deletion of 16 nucleotides between positions 394 and 409, causing a translational frameshift with a predicted alternate stop codon (p.K132Wfs*33). this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |